Zhiyu Zeng

Zhiyu Zeng


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2017 in Frontiers in Physiology
Verified
Journal Article
Open access
BLBeibei Luo
Beibei Luo
FHFeng Huang
Feng Huang
YLYanli Liu
Yanli Liu
YLYiying Liang
Yiying Liang
ZWZhe Wei
Zhe Wei
YHYan He
Yan He
Diabetic cardiomyopathy (DCM), a common consequence of longstanding diabetes mellitus, is initiated by death of cardiomyocyte. Hyperglycemia-induced reactive oxygen species (ROS) overproduction is a major contributor of the chronic low-grade inflammation that characterizes as the DCM. ROS may promote the activation of nucleotide-binding oligomerization domain like receptor (NLR) pyrin domain containing 3 (NLRP3) inflammasome, a novel regulator of inflammation and cell death, by nuclear factor-kB (NF-kB) and thioredoxin interacting/inhibiting protein (TXNIP). NLRP3 inflammasome regulates the death of cardiomyocyte and activation of fibroblast in DCM, which is involved in the structural and functional disorder of DCM. However, comprehensive understanding of molecular mechanisms linking NLRP3 inflammasome and disorder of cardiomyocyte and fibroblast in DCM is lacking. Here we review the molecular mechanism(s) of NLRP3 inflammasome activation in response to hyperglycemia in DCM.

2 May 2014 in European Journal of Heart Failure
Verified
Journal Article
Open access
PDF file
RTRong-Hui Tu
Rong-Hui Tu
ZZZhiyu Zeng
Zhiyu Zeng
GZGuo-Qiang Zhong
Guo-Qiang Zhong
WWWei-Feng Wu
Wei-Feng Wu
YLYun-Juan Lu
Yun-Juan Lu
LYLi-Mei Yao
Li-Mei Yao
Aims: The aim of this review is to assess the effects of exercise training on the symptoms of depression in heart failure (HF) patients. Methods and results: Randomized controlled trials of exercise training in patients with HF and symptoms of depression were identified. The depression data were pooled using meta-analysis, and 19 studies were identified, with a total of 3447 patients, of which 16 (3226 patients) provided data for the meta-analysis. Exercise training demonstrated significant reductions in the symptoms of depression [standardized mean difference (SMD) –0.38, 95% confidence interval (CI) –0.55 to −0.21], and its antidepressive effect was consistent in a number of HF groups, such as in ages under and over 65 years (SMD −0.14, 95% CI −0.22 to −0.07 vs. SMD −0.44, 95% CI −0.61 to −0.27) and EFs of 26 weeks, SMD −0.12, 95% CI −0.20 to −0.04). The beneficial effects were preserved when blind design trials were considered (SMD −0.14, 95% CI −0.22 to −0.07). Conclusion: Exercise training significantly decreased the symptoms of depression in patients with HF. This benefit remained unclear in cases of HF with a normal EF and combined aerobic and strength training. Random controlled trials are needed to verify the benefit of exercise in these populations, and in very old, asymptomatic, and severe HF patients.

10 December 2013 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
SLShan Li
Shan Li
XHXiu-Li Huang
Xiu-Li Huang
JSJing-Zhe Sui
Jing-Zhe Sui
SCSi-Yuan Chen
Si-Yuan Chen
YXYan-Tong Xie
Yan-Tong Xie
ZZZhiyu Zeng
Zhiyu Zeng

1 November 2015 in Cardiovascular Pathology
Verified
Journal Article
Closed access
YWYun Wen
Yun Wen
ZZZhiyu Zeng
Zhiyu Zeng
CGChun Gui
Chun Gui
LLLang Li
Lang Li
WLWenting Li
Wenting Li

6 December 2019 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
ACAng Chen
Ang Chen
JWJianlin Wen
Jianlin Wen
CLChuanghong Lu
Chuanghong Lu
BLBeiyou Lin
Beiyou Lin
SXShenglin Xian
Shenglin Xian
ZZZhiyu Zeng
Zhiyu Zeng
Autoimmunity is involved in the valvular damage caused by rheumatic heart disease (RHD). Increased evidence has linked microRNAs (miRNAs/miRs) to autoimmune disease. Signal transducer and activator of transcription 3 (STAT3) and sphingosine‑1‑phosphate receptor 1 (S1PR1) and suppressor of cytokine signaling 1 (SOCS1) have been widely studied for their roles in autoimmunity and inflammation. Thus, the current study aims to investigate the role played by miR‑155‑5p in RHD‑induced valvular damage via the S1PR1, SOCS1/STAT3 and interleukin (IL)‑6/STAT3 signaling pathways. An RHD rat model was induced by inactivated Group A streptococci and complete Freund's adjuvant. A recombinant adeno‑associated virus (AAV‑miR155‑inhibitor) was used to inhibit the expression of miR‑155‑5p in the heart. Inflammation and fibrosis were assessed by hematoxylin and eosin staining and Sirius red staining. The expression of miR‑155‑5p in valvular tissues and serum exosomes was detected by reverse transcription‑quantitative PCR. S1PR1, SOCS1, STAT3, phosphorylated STAT3, IL‑6 and IL‑17 protein expression was detected by western blotting and immunohistochemistry. The relationships between miR‑155‑5p and S1PR1 and SOCS1 were detected by dual luciferase assays. Cytokine concentrations were measured by ELISA. The expression of miR‑155‑5p in valve tissues and serum exosomes was increased along with decreased S1PR1 and activated SOCS1/STAT3 signaling in the RHD model. The expression of IL‑6 and IL‑17 was increased in the valves and the serum. Dual luciferase assays showed that miR‑155‑5p directly targeted S1PR1 and SOCS1. Inhibition of valvular miR‑155‑5p through AAV pretreatment increased S1PR1 expression and inhibited activation of the SOCS1/STAT3 signal pathway as a result of attenuated valvular inflammation and fibrosis as well as a decrease in IL‑6 and IL‑17 in the valves and serum. These results suggest that inhibition of miR‑155‑5p can reduce RHD‑induced valvular damage via the S1PR1, SOCS1/STAT3 and IL‑6/STAT3 signaling pathways.

29 April 2025 in Communications Biology
Verified
Journal Article
Open access
PDF file
STSenhu Tang
Senhu Tang
CLChuanghong Lu
Chuanghong Lu
ZMZhongyuan Meng
Zhongyuan Meng
ZYZihua Ye
Zihua Ye
YQYue Qin
Yue Qin
ZZZhiyu Zeng
Zhiyu Zeng
Atherosclerosis is a chronic inflammatory disease that strongly threatens human health, and macrophages play a pivotal role in its pathogenesis. Ubiquitin-specific peptidase 22 (USP22) is involved in the regulation of macrophage inflammation. However, its role in the atherosclerotic microenvironment remains unclear. In this study, we found that USP22 overexpression in macrophages alleviated atherosclerosis progression in ApoE−/− mice. In vitro, USP22 silencing enhanced macrophage inflammation and foam cell formation, and macrophage efferocytosis was significantly impaired. Mechanistically, USP22 bound to peroxisome proliferator-activated receptor γ (PPARγ) and inhibited its ubiquitination, thereby stabilizing PPARγ and promoting efferocytosis. In addition, intraperitoneal injection of the USP22 inhibitor USP22i-S02 exacerbated atherosclerosis in ApoE−/− mice. In summary, these findings indicate that USP22 may be a potential therapeutic target for the treatment of atherosclerosis.